Author:
Jang Julie K.,Khawli Leslie A.,Canter David C.,Hu Peisheng,Zhu Tian H.,Wu Brian W.,Angell Trevor E.,Li Zhongjun,Epstein Alan L.
Funder
National Cancer Institute
National Center for Advancing Translational Sciences
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Immunology,Immunology and Allergy
Reference50 articles.
1. Wiemann B, Starnes CO (1994) Coley’s toxins, tumor necrosis factor and cancer research: a historical perspective. Pharmacol Ther 64:529–564
2. Coley WB (1991) The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. 1893. Clin Orthop Relat Res 262:3–11
3. Lechner MG, Karimi SS, Barry-Holson K, Angell TE, Murphy KA, Church CH, Ohlfest JR, Hu P, Epstein AL (2013) Immunogenicity of murine solid tumor models as a defining feature of in vivo behavior and response to immunotherapy. J Immunother 36:477–489. doi:
10.1097/01.cji.0000436722.46675.4a
4. Liu Y, Zeng G (2012) Cancer and innate immune system interactions: translational potentials for cancer immunotherapy. J Immunother 35:299–308. doi:
10.1097/CJI.0b013e3182518e83
5. Tokunaga T, Yamamoto H, Shimada S et al (1984) Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. J Natl Cancer Inst 72:955–962
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献